Avita Medical appoints CEO
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Avita Medical Ltd. appointed Michael Perry as CEO, effective June 2.
Previously, Perry has served as senior vice president and chief scientific officer of global business development and licensing for Novartis AG.
